who should not take bpc 157 Peptide BPC-157 The Hidden Risks of BPC‑157:

The trusted bacteriostatic water choice for laboratory research and peptide solubilization protocols across the United States

Another Example: Lower Dose Scenario: Same vial (10 mg + 2 ml BAC = 5 mg/ml)

For most general applications, mixing with 2mL or 4mL of bacteriostatic water provides a great balance of concentration and ease of measurement

Bottom Line BPC-157 is an unapproved drug

Patients may experience mild to severe infusion reactions such as chills, itching, high temperature, hives, difficulty breathing, and chest pain

A formal Phase I human safety trial was started in 2015, but the sponsor In the world of drug development, this is a massive red flag that strongly suggests a problem was found